Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Apricus Biosciences Inc Appoints Richard W. Pascoe as Chief Executive Officer


Monday, 18 Mar 2013 11:00am EDT 

Apricus Biosciences Inc announced the appointment of Richard W. Pascoe as Chief Executive Officer(CEO) of the Company, effective March 18, 2013. In addition to his role as CEO, he has also joined the Company's Board of Directors. With Mr. Pascoe's appointment, Steve Martin, Interim CEO, will resume his responsibilities as Senior Vice President and Chief Financial Officer. 

Company Quote

1.35
-0.02 -1.46%
1:08pm EST